AI Summary Kemstro (baclofen orally disintegrating tablet) is a prescription medication used off label for alcohol use disorder that dissolves on the tongue without water.
Medically reviewed.
Kemstro (baclofen orally disintegrating tablet) is a prescription medication that doctors use off label to help reduce alcohol cravings in alcohol use disorder (AUD). It dissolves on the tongue, so you do not need water. It works much like Lioresal (baclofen tablets) and is designed for people who prefer or need this form. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Kemstro's role in AUD care: how it works, who may be eligible, how it is used, benefits, side effects, and follow-up. You can also connect with a liver specialist near you for personalized guidance on whether Kemstro fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT KEMSTRO TREATMENT
Kemstro is a prescription medicine that contains baclofen, in the form of an orally disintegrating tablet. The tablet dissolves on your tongue. Doctors use it off label to help reduce alcohol cravings in alcohol use disorder (AUD). Off label means the medicine is used for a purpose the FDA has not specifically approved.
Kemstro works much like Lioresal, the baclofen tablet. It is designed for people who prefer or need a tablet that dissolves instead of one they swallow whole.
Kemstro does not treat liver damage directly. It supports stopping or reducing alcohol use, and doctors may consider it for people who also have alcohol-related liver disease. It is used alongside counseling or a recovery program, with routine follow-up, such as Liver Function Tests (LFTs).
WHO KEMSTRO MAY BE SUITABLE FOR
Eligibility for Kemstro depends on your alcohol use history, your liver health, and your individual needs. Doctors may consider it for people with AUD who need help with cravings or relapse prevention. It may also suit people who have trouble swallowing standard tablets, or who need a different form of baclofen.
Kemstro is not FDA-approved specifically for AUD. The American Association for the Study of Liver Diseases (AASLD) notes that baclofen, gabapentin, and topiramate are often used off label, and that providers consider them when first-line medicines are contraindicated or not tolerated. The AASLD also notes that baclofen does not undergo significant hepatic (liver) metabolism, so it may be a reasonable option for people with alcohol-related liver disease. Your doctor will still monitor your liver health, especially if your disease is advanced.
Because every patient's health profile is different, there is no one-size-fits-all answer. Treatment decisions should be made by a qualified healthcare professional after a full assessment of your alcohol use, liver condition, and treatment goals.
ELIGIBILITY OVERVIEW
Your healthcare provider may prescribe Kemstro if you have:
Before recommending Kemstro, healthcare providers look at several factors, including:
HOW KEMSTRO CAN HELP
Kemstro activates GABA-B receptors in the brain. This action reduces the intensity of alcohol cravings and helps ease anxiety during recovery. Together, these effects support relapse prevention.
Kemstro provides a similar effect to baclofen tablets (Lioresal). The main difference is the form: the tablet dissolves on the tongue, and you do not need water.
Baclofen has been studied in people with liver disease. The AASLD notes that it does not undergo significant hepatic (liver) metabolism. The European Association for the Study of the Liver (EASL) states that baclofen has been tested and shown to be safe and effective in promoting abstinence in people with alcohol-related liver disease and cirrhosis. Still, clinicians are advised to use caution and monitor liver function, especially in advanced disease.
Kemstro is not used on its own. Providers pair it with counseling or a recovery program and regular follow-up.
RECOVERY BENEFITS
Kemstro is not used on its own. Providers pair it with counseling or a recovery program. The medicine helps with cravings, and counseling helps build lasting change.
Routine follow-up lets your provider see how well Kemstro works and how well you tolerate it. Your provider will ask how you feel, including whether anxiety has eased, and may adjust your dose gradually based on your response.
Treatment generally continues for several months or longer. The length depends on craving control, relapse risk, and your overall recovery progress. Do not stop taking Kemstro without first talking to your provider.
Kemstro does not treat liver damage directly. If you have liver disease, your provider may check your liver function during follow-up and adjust your care plan as your recovery progresses.
Kemstro helps reduce alcohol cravings and supports relapse prevention. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Kemstro is supplied as an orally disintegrating tablet. Take it exactly as prescribed by your healthcare provider.
The typical starting dose is 5 mg three times daily. Your provider gradually increases it based on your response and how well you tolerate it. Maintenance doses commonly range from 30 to 80 mg daily, split into divided doses. Your healthcare provider determines the right dose for you.
Place the tablet on your tongue and let it dissolve completely before swallowing. You do not need water. Do not change your dose without medical guidance.
Treatment generally continues for several months or longer. The length depends on craving control, relapse risk, and your overall recovery progress. Do not stop taking Kemstro without first talking to your healthcare provider.
Store Kemstro at room temperature, away from moisture.
Routine follow-up helps your provider assess how well Kemstro works and how well you tolerate it. If you have liver disease, your provider may also check liver function. Report any side effects or unusual symptoms to your provider.
BENEFITS AND SAFETY
Kemstro may support people with AUD by reducing alcohol cravings and easing anxiety during recovery, which helps prevent relapse. For some people with liver disease, it is an option when other medicines are limited. The extent of these benefits varies from person to person. Kemstro is not a stand-alone treatment. It works best as part of a broader care plan that includes counseling or a recovery program, complete alcohol abstinence, and ongoing follow-up like Liver Function Tests (LFTs).
As with any medication, Kemstro may cause side effects. The most common are drowsiness and dizziness. Your healthcare provider will assess whether Kemstro is a suitable option for you and will follow your response throughout treatment.
BENEFITS
Kemstro reduces the intensity of alcohol urges. Fewer strong cravings can make it easier to stay committed to your recovery plan from day to day.
By easing cravings and anxiety, Kemstro supports sustained sobriety. It is meant to be used together with complete alcohol abstinence and a recovery program, not as a replacement for them.
The tablet dissolves on your tongue, so you do not need water. This can help people who have trouble swallowing standard tablets or who prefer a different form of baclofen.
For some people with liver disease, Kemstro may be an option when other medicines are limited. Your provider decides whether it fits your situation and follows your liver health during treatment.
Avoid driving or operating machinery until you know how the medication affects you. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support to ensure safe use.
SUPPORTING YOUR RECOVERY
Lifestyle changes are an important part of your care plan alongside Kemstro. Medication helps with cravings, and counseling and recovery programs help build lasting change.
These habits can support your recovery and your liver health over time.
Areas that may support treatment:
common questions
No, Kemstro is used off label for alcohol use disorder. Off label means doctors use the medicine for a purpose the FDA has not specifically approved. The AASLD notes that baclofen, gabapentin, and topiramate are often used off label, and that providers consider them when first-line medicines are contraindicated or not tolerated. Talk with your healthcare provider about whether Kemstro fits your alcohol use history, your liver health, and your care plan.
Kemstro is an orally disintegrating tablet, and Lioresal is a standard tablet you swallow whole. Both contain baclofen and have a similar effect. Kemstro dissolves on your tongue and needs no water, so it may suit people who have trouble swallowing tablets or who need a different form of baclofen. Your provider can help you choose the form that fits you.
Yes, it may be an option in selected patients, but safety depends on your condition. The AASLD notes baclofen does not undergo significant hepatic metabolism. The EASL states it has been tested and shown to be safe and effective in promoting abstinence in people with alcohol-related liver disease and cirrhosis. Clinicians still use caution and monitor liver function, especially in advanced disease, so your provider may check your liver during follow-up.
Place the tablet on your tongue and let it dissolve completely before swallowing. You do not need water. Take it exactly as prescribed. Providers usually start with a low dose and increase it gradually, based on how you respond and how well you tolerate it. Do not change your dose on your own, and store the tablets at room temperature, away from moisture.
Treatment generally continues for several months or longer. Your provider decides the length based on craving control, relapse risk, and your recovery progress, and reviews it at routine follow-up visits. Do not stop taking Kemstro without talking to your provider first.
The most common side effects are drowsiness and dizziness. Others include fatigue, weakness, and headache. Avoid driving or operating machinery until you know how Kemstro affects you. Report any side effects or unusual symptoms to your healthcare provider, who will weigh the benefits and risks with you and support safe use.
No. Patients are encouraged to maintain complete alcohol abstinence while taking Kemstro, and to take part in counseling or a recovery program. Kemstro helps reduce cravings and supports recovery, but it does not replace these steps. If you find it hard to stop drinking, tell your provider so they can adjust your care plan.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
